ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 575

Differences in Histological Scores and Histoclinical Correlations in ACPA- Versus ACPA+ Rheumatoid Arthritis Patients

Fadil Pirbuccus1, Christine Galant1, Adrien Nzeusseu Toukap2, Frédéric A. Houssiau1, Patrick Durez2 and Bernard R. Lauwerys1, 1Pôle de pathologies rhumatismales inflammatoires et systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 2Pôle de Maladies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ACPA, pathogenesis and synovitis, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Differences in the pathogenesis of ACPA- versus ACPA+ rheumatoid arthritis are still poorly understood. In this study, we compared patterns of synovial changes in both disorders, and how they correlate with clinical parameters of disease activity.

Methods:  Semi-quantitative histological scores (0-3) on synovial hyperplasia, diffuse and perivascular lymphocytic infiltrates, vascular hypertrophy and fibrinoid necrosis were obtained retrospectively from 62 ACPA+ and 29 ACPA- synovial biopsies, obtained by needle-arthroscopy from the knee of rheumatoid arthritis patients. Clinical and biological indices of disease activity (DAS28-CRP, SDAI, CDAI and their individual components) were retrieved from the medical records at the time of biopsy (T0), and 6 months later. IL6 and IL6R immunostainings were performed on a subset of the samples. High-throughput transcriptomic data were available for 14 ACPA+ and 6 ACPA- patients.

Results: Synovial hyperplasia, vascular hypertrophy and fibrinoid necrosis scores were significantly higher in ACPA- compared to ACPA+ patients. Diffuse and perivascular lymphocytic infiltrates also scored higher in ACPA- patients, but the difference was not significant. Clinical and biological indices of disease activity were similar in both groups, as were IL6 and IL6R immunostaining quantifications. In ACPA+ patients, all (except vascular hypertrophy) histological scores correlated with clinical and/or biological scores of disease activity at T0. Fibrinoid necrosis in ACPA+ patients also correlated with disease activity 6 months later. By contrast, none of the histological scores displayed any correlation with disease activity measures in ACPA- patients. Transcriptomic analyses demonstrated a significant correlation between synovial hyperplasia and a T cell activation signature (e.g. IL6R, IL23R) in ACPA+ biopsies. This correlation was also present in ACPA- samples, but stronger correlations were found in this group with transcripts pointing at the activation of other T cell related pathways, such as IL10 and TGFβ2.

Conclusion:  Synovial biopsies from ACPA- versus ACPA+ rheumatoid arthritis patients display different histological characteristics and histoclinical correlations. In particular, synovial biopsies from ACPA- patients have a higher cellularity, yet are associated with similar clinical disease activity. Preliminary transcriptomic data point at the presence of regulatory cells in ACPA- synovial tissue, as a potential explanation to this discrepancy.


Disclosure: F. Pirbuccus, None; C. Galant, None; A. Nzeusseu Toukap, None; F. A. Houssiau, None; P. Durez, None; B. R. Lauwerys, None.

To cite this abstract in AMA style:

Pirbuccus F, Galant C, Nzeusseu Toukap A, Houssiau FA, Durez P, Lauwerys BR. Differences in Histological Scores and Histoclinical Correlations in ACPA- Versus ACPA+ Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/differences-in-histological-scores-and-histoclinical-correlations-in-acpa-versus-acpa-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differences-in-histological-scores-and-histoclinical-correlations-in-acpa-versus-acpa-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology